Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 45Neoplasm Metastasis 6Glioma 6Glioblastoma 6Neoplasms 5Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Ovarian Neoplasms 3Liposarcoma 3Diffuse Intrinsic Pontine Glioma 3Astrocytoma 3Recurrence 2Prostatic Neoplasms 2Meningioma 2Medulloblastoma 2Fallopian Tube Neoplasms 2Breast Neoplasms, Male 2Breast Cancer Metastatic 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thymus Neoplasms 1Sarcoma, Synovial 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Oligodendroglioma 1Non functioning pancreatic endocrine tumor 1Neurofibrosarcoma 1

Interventions

Imatinib Mesylate 3Doxorubicin 3pazopanib 2Mohs Surgery 2Gemcitabine 2Docetaxel 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2selinexor 1ribociclib 1pembrolizumab 1avelumab 1Sunitinib 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Quality of Life 1Proton Therapy 1Polymerase Chain Reaction 1Nivolumab 1Neoadjuvant Therapy 1Ifosfamide 1Gene Expression Profiling 1Dexrazoxane 1Dactinomycin 1Cyclophosphamide 1Blotting, Western 1Blood Specimen Collection 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dermatofibrosarcoma × ribociclib × Clear all
NCT03009201 2023-08-16

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 1 Completed
16 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Disorders of Sex Development, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡